Literature DB >> 30629308

Effect of treatment modality on chronic opioid use in patients with T1/T2 oropharyngeal cancer.

Craig A Bollig1, Jeffrey B Jorgensen1.   

Abstract

BACKGROUND: The effect of treatment modality on long-term opioid dependence in patients with oropharyngeal cancer has not been reported.
METHODS: A retrospective cohort of 122 patients with T1/T2 oropharyngeal cancer undergoing treatment was generated. Risk factors associated with chronic opioid use were investigated by univariate and multivariate analyses.
RESULTS: The prevalence of chronic opioid use was 45.9%. On multivariate analysis, primary nonsurgical treatment (odds ratio [OR] 4.5, 95% confidence interval [CI]: 1.7-11.4), pretreatment opioid use (OR 14.9, 95% CI: 3.5-62.5), psychiatric disorder (OR 4.3, 95% CI: 1.03-18.5), alcohol use (OR 2.6, 95% CI: 1.03-6.5), and younger age (OR 1.1, 95% CI: 1.02-1.11) were significantly associated with chronic opioid use.
CONCLUSION: Primary nonsurgical treatment, younger age, pretreatment opioid use, alcohol use, and psychiatric disorder were independently associated with an increased risk of chronic opioid use. Preventative strategies should be especially focused toward these patients to reduce their risk of long-term opioid use.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  TORS; chronic opioid use; oropharyngeal cancer; perioperative pain; quality of life

Year:  2019        PMID: 30629308     DOI: 10.1002/hed.25482

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  2 in total

1.  Risk of Chronic Opioid Use After Radiation for Head and Neck Cancer: A Systematic Review and Meta-Analysis.

Authors:  Sondos Zayed; Cindy Lin; R Gabriel Boldt; Jinka Sathya; Varagur Venkatesan; Nancy Read; Lucas C Mendez; Dwight E Moulin; David A Palma
Journal:  Adv Radiat Oncol       Date:  2020-10-26

2.  Prognostic Impact of Metastatic Site and Pattern in Patients with Metastatic Head and Neck Cancer.

Authors:  Craig A Bollig; Christopher I Newberry; Tabitha L I Galloway; Robert P Zitsch; Elyse K Hanly; Vivian L Zhu; Nitin Pagedar; Rohit Nallani; Andres M Bur; William C Spanos; Jeffrey B Jorgensen
Journal:  Laryngoscope       Date:  2020-10-24       Impact factor: 3.325

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.